Expression Table for this CRE
| CNhs14299 | macrophage, TB infection, non-stimulated BMDM, without Mtb, 048hr, biol_rep3 | 53.5 |
| CNhs14123 | ES-46C derived epistem cells, biol_rep1 | 27.9 |
| CNhs14122 | ES-OS25 embryonic stem cells, KD for exosomal component EXOSC5, biol_rep2 | 25.9 |
| CNhs14109 | ES-46C embryonic stem cells, neuronal differentiation, day00, biol_rep2 | 19.8 |
| CNhs14121 | ES-OS25 embryonic stem cells, KD for exosomal component EXOSC5, biol_rep1 | 17.7 |
| CNhs14118 | ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 | 16.6 |
| CNhs14110 | ES-46C embryonic stem cells, neuronal differentiation, day01, biol_rep2 | 15.2 |
| CNhs14113 | ES-46C embryonic stem cells, neuronal differentiation, day04, biol_rep2 | 14.5 |
| CNhs14119 | ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep2 | 12.8 |
| CNhs14115 | ES-OS25 embryonic stem cells, untreated siRNA control, biol_rep2 | 11.9 |
| CNhs14117 | ES-OS25 embryonic stem cells, scrambled siRNA control, biol_rep2 | 11.7 |
| CNhs14116 | ES-OS25 embryonic stem cells, scrambled siRNA control, biol_rep1 | 11.2 |
| CNhs14112 | ES-46C embryonic stem cells, neuronal differentiation, day03, biol_rep2 | 9.9 |
| CNhs14114 | ES-OS25 embryonic stem cells, untreated siRNA control, biol_rep1 | 9.9 |
| CNhs13263 | ST2 (Mesenchymal stem cells) cells, differentiation to osteocytes, 03hr, biol_rep2 (003hB2) | 9.5 |
| CNhs10592 | pituitary gland, embryo E15 | 9.4 |
| CNhs10584 | kidney, embryo E16 | 8.9 |
| CNhs14104 | ES-46C embryonic stem cells, neuronal differentiation, day00, biol_rep1 | 6.6 |
| CNhs14108 | ES-46C embryonic stem cells, neuronal differentiation, day04, biol_rep1 | 6.6 |
| CNhs14091 | ES-OS25 embryonic stem cells, untreated control, biol_rep1 | 6.5 |
| CNhs12772 | J2E erythroblastic leukemia response to erythropoietin, 00hr30min, biol_rep3 | 6.5 |
| CNhs13821 | visual cortex - Mecp knockout, neonate N15, donor3 | 6.4 |
| CNhs14090 | ES-OS25 embryonic stem cells, flavopiridol treatment, 01hr, biol_rep3 | 6.2 |
| CNhs12451 | J2E erythroblastic leukemia response to erythropoietin, 03hr30min, biol_rep1 | 6.1 |
| CNhs14105 | ES-46C embryonic stem cells, neuronal differentiation, day01, biol_rep1 | 6.0 |
| CNhs14337 | natural helper cells, IL33 treated, day02, biol_rep2 | 6.0 |
| CNhs11206 | kidney, neonate N10 | 5.9 |
| CNhs12508 | natural helper cells, IL2 treated, day15, biol_rep2 | 5.8 |
| CNhs11058 | EBF KO HPCs induced to T cell, 00hr00min, biol_rep1 | 5.8 |
| CNhs14089 | ES-OS25 embryonic stem cells, flavopiridol treatment, 01hr, biol_rep2 | 5.6 |
| CNhs14094 | ES-OS25 embryonic stem cells, aminitin treatment for 7hr, biol_rep1 | 5.4 |
| CNhs12450 | J2E erythroblastic leukemia response to erythropoietin, 03hr00min, biol_rep1 | 5.3 |
| CNhs10601 | liver, embryo E12 | 5.3 |
| CNhs12513 | natural helper cells, IL33 treated, 01hr, biol_rep3 | 4.9 |
| SRX7078888 | IPMN cell lines derived from mouse models of pancreatic cancer: Ptf1a-Cre; KrasG12D; Brg1f/f PDA | 4.8 |
| CNhs14085 | ES-OS25 embryonic stem cells, DMSO control, biol_rep1 | 4.8 |
| CNhs12612 | Mouse Neurons - substantia nigra, donor4 | 4.8 |
| CNhs14088 | ES-OS25 embryonic stem cells, flavopiridol treatment, 01hr, biol_rep1 | 4.6 |
| CNhs14086 | ES-OS25 embryonic stem cells, DMSO control, biol_rep2 | 4.5 |
| CNhs14087 | ES-OS25 embryonic stem cells, DMSO control, biol_rep3 | 4.5 |
| CNhs14153 | hematopoietic stem cell, fetal liver derived, embryo E12.5 | 4.5 |
| CNhs14156 | hematopoietic stem cell, bone marrow derived, newborn 2-3months | 4.5 |
| CNhs14101 | ES-Ert2 embryonic stem cells, tamoxifen treated, 48hr, biol_rep1 | 4.5 |
| CNhs13792 | Tracheal epithelial cells, differentiation to ciliated epithelial cells, 120hr, biol_rep3 | 4.4 |
| CNhs10599 | pancreas, embryo E17 | 4.4 |
| CNhs10510 | liver, embryo E17 | 4.4 |
| CNhs11020 | lung, embryo E15 | 4.4 |
| CNhs14100 | ES-Ert2 embryonic stem cells, untreated control, 48hr, biol_rep3 | 4.3 |
| CNhs13019 | cerebellum, embryo E16, biol_rep3 (E16R3) | 4.2 |
| CNhs11118 | heart, neonate N10 | 4.2 |